This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $4,036.04 and a performance period ending on September 27, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $3,990.94, is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed price delivery order with a completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This order is placed...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, and has a ceiling value of $8,315.10. The contract is a Firm Fixed Price delivery order with a period of performance ending on September 13, 2024. Amerisourcebergen is a large pharmaceutical distributor that holds multiple Indefinite Delivery...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $8,679.11 and a completion date of June 23, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a $11,265.59 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the medication REXULTI 1 MG TABLET 30S. The contract has an ultimate completion date of April 17, 2025 and is not designated as a set-aside. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,249,991 units of the pharmaceutical product REXULTI 2 MG TABLET 30S. The $16,052.19 delivery order has a completion date of January 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, regularly provides pharmaceutical products and medical supplies to support DLA programs from its...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product REXULTI 1 MG TABLET 30S. The contract, valued at $1,436.77, has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this award. This delivery order...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,230.39 contract is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of June 14, 2024 and is a Firm Fixed Price contract. There is no set-aside designation mentioned for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $10,349.86 contract is for the delivery of the pharmaceutical product REXULTI 1 MG TABLET 30S. It has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $5,001.05, is for the delivery of the pharmaceutical product REXULTI 0.5 MG TABLET 30S. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...